Boswellia serrata, also known as Indian frankincense, is a resin extract used for centuries in traditional medicine and now studied for joint health. A recent body of clinical research has looked specifically at whether it can ease the pain and stiffness of osteoarthritis — and the findings are encouraging, though not without important caveats.

What the research looked at

A systematic review and meta-analysis pooled data from seven randomized controlled trials, covering a total of 545 patients with osteoarthritis. Randomized controlled trials are considered the gold standard for testing whether a treatment actually works, and combining several of them in a meta-analysis gives a more reliable picture than any single study alone. The trials compared Boswellia serrata extract against control treatments (such as placebo or standard care) and tracked outcomes including pain, stiffness, and joint function over time.

What it found

Across the pooled trials, Boswellia serrata extract relieved pain and stiffness and improved joint function compared with the control treatments. The researchers noted that benefits were associated with a recommended treatment duration of at least four weeks — in other words, this is not a fast-acting painkiller, but an ingredient that appears to work gradually with continued use. Separately, larger network meta-analyses that compared many different joint supplements against one another have ranked Boswellia among the more effective options for short-term pain reduction, adding some independent support to the findings from the smaller pooled analysis.

What it means (and the limits)

Taken together, this research suggests Boswellia serrata extract is a reasonable, generally well-tolerated option to consider for supporting joint comfort in osteoarthritis, particularly when used consistently for a month or longer. It is not a cure, and it will not repair damaged cartilage or reverse osteoarthritis — the evidence describes symptom relief, not disease modification. It is also worth remembering that seven trials and 545 patients, while a meaningful body of evidence, is still a modest dataset compared with what exists for many conventional medicines, so conclusions should be held with appropriate caution.

Choosing a product

One practical point from the research is that extract strength, dose, and overall product quality vary considerably between brands. Because outcomes in the studies depended on the specific extract and dose used, consumers should read product labels carefully and not assume that all Boswellia products, or all doses, will deliver the same effect.

Sources: https://link.springer.com/article/10.1186/s12906-020-02985-6 · https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368679/

Dual-action joint collagen

Mafsal Riyadi combines the two collagen types most studied for joints — high-tripeptide hydrolyzed collagen and undenatured type II collagen — in one licensed dietary supplement (EDA reg. no. 14711/2026). Research about ingredient categories is general and is not a claim about any individual product.

Learn about Mafsal Riyadi

This is a plain-language summary of published research for general education. It is not medical advice, a diagnosis, or a treatment recommendation, and individual studies have limitations. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor or pharmacist about your own situation.